---
title: "Shifeng Cultural established a new company for smart green electricity technology"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248536296.md"
description: "According to the Qichacha APP, recently, Shantou Shifeng Smart Green Power Technology Co., Ltd. was established, with Li Kai as the legal representative. The business scope includes solar power generation technology services; photovoltaic power generation equipment leasing; sales of new energy prime mover equipment, etc. Qichacha's equity penetration shows that the company is wholly owned by Shifeng Cultural indirectly"
datetime: "2025-07-15T06:03:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248536296.md)
  - [en](https://longbridge.com/en/news/248536296.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248536296.md)
generator: "portal-rs"
---

# Shifeng Cultural established a new company for smart green electricity technology

According to the Qichacha APP, recently, Shantou Shifeng Smart Green Power Technology Co., Ltd. was established, with Li Kai as the legal representative. The business scope includes solar power generation technology services; photovoltaic power generation equipment leasing; sales of new energy prime mover equipment, etc. Qichacha's equity penetration shows that the company is wholly owned by Shifeng Cultural indirectly

### Related Stocks

- [002862.CN](https://longbridge.com/en/quote/002862.CN.md)

## Related News & Research

- [SpyCloud 2026 Identity Threat Report Finds Non-Human Identities Are Now the Leading Path into the Enterprise](https://longbridge.com/en/news/298456224.md)
- [Havas, linked to Louis Hachette director Yannick Bolloré, purchases EUR 5.31 million of Louis Hachette Group shares](https://longbridge.com/en/news/298621675.md)
- [Climeworks says upgraded Mammoth units more than double CO₂ capture performance](https://longbridge.com/en/news/298546691.md)
- [Webuild denies seeking €22 billion in extra costs from Italian government](https://longbridge.com/en/news/298431926.md)
- [Alpha-9 Oncology doses first patient in Phase 1 trial of GRPR-targeted radiotherapeutics](https://longbridge.com/en/news/298604842.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**